Clinical trial
ASPREE Cancer Endpoints Study
NCT01968798 is registered in ClinicalTrials.gov with Hennepin Healthcare Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ASPREE Cancer Endpoints Study
- Lead sponsor
- Hennepin Healthcare Research Institute
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 30, 2013
- Completion date
- April 30, 2024
- Enrollment
- 14,500 (estimated)
- Sites
- 40
Conditions
As the registry lists them; a condition with its own page is linked.
cancer